Lurbinectedin is a chemotherapy drug that is used to treat small cell lung cancer. As with any medication, there are potential side effects that may occur. According to the Mayo Clinic [2], some of the most common side effects of lurbinectedin include nausea, vomiting, constipation, and fatigue. Other potential side effects may include a decrease in white blood cell count, which can increase the risk of infection, and anemia, which can cause fatigue and shortness of breath.

In addition to these common side effects, there are also some more serious potential side effects that may occur. According to Zepzelca [3], lurbinectedin can cause severe allergic reactions in some people. Signs of an allergic reaction may include difficulty breathing, hives, and swelling of the face, lips, tongue, or throat. If you experience any of these symptoms, it is important to seek medical attention immediately.

Other potential serious side effects of lurbinectedin may include a decrease in platelet count, which can increase the risk of bleeding, and liver problems, which can cause yellowing of the skin or eyes, dark urine, and abdominal pain. If you experience any of these symptoms, it is important to contact your healthcare provider right away.

It is important to note that not everyone will experience side effects from lurbinectedin, and the severity of side effects can vary from person to person. If you are concerned about potential side effects, it is important to talk to your healthcare provider before starting treatment.

Sources:
[2] Mayo Clinic. (2021). Lurbinectedin (Intravenous Route) - Side Effects. Retrieved from https://www.mayoclinic.org/drugs-supplements/lurbinectedin-intravenous-route/side-effects/drg-20490804?p=1
[3] Zepzelca. (2021). Side Effects. Retrieved from https://www.zepzelca.com/zepzelca-side-effects/
[4] Drug Patent Watch. (2021). Lurbinectedin Trademark Details. Retrieved from https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN